e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictive value of a whole-blood IGRA for the development of active TB disease
R. Diel, R. Loddenkemper, A. Nienhaus (Duesseldorf, Berlin, Hamburg, Germany)
Source:
Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Session:
Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Session type:
Oral Presentation
Number:
4578
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Diel, R. Loddenkemper, A. Nienhaus (Duesseldorf, Berlin, Hamburg, Germany). Predictive value of a whole-blood IGRA for the development of active TB disease. Eur Respir J 2008; 32: Suppl. 52, 4578
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts
Source: Eur Respir J 2010; 35: 1346-1353
Year: 2010
Accuracy of whole blood IGRA in TB subjects with rheumatic disease.
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Value of QFT-IT test for diagnosing latent TB infection in HIV+
Source: ISSN=ISSN 1810-6838, ISBN=, page=284
Year: 2007
Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014
Comparison between tuberculin skin testing and QuantiFERON Gold-In Tube for detection of latent tuberculosis in rheumatoid arthritis patients in a TB endemic population
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Evaluation of IP-10 in IGRA for LTBI diagnosis
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Clinical management of LTBI (PDF)// IGRAs for the diagnosis of tuberculosis (PPT)
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Poor agreement between whole-blood IFN-? assay and TST for the diagnosis of latent TB infection in children
Source: ISSN=ISSN 1810-6838, ISBN=, page=378
Year: 2007
Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Source: Eur Respir J 2016; 48: 1751-1763
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept